Chen‐Qian Liu
Papers
1
Total Citations
7
H-Index
1
About
Chen-Qian Liu is a leading urologic oncology researcher whose work centers on optimizing surgical outcomes for prostate cancer patients. His most impactful contribution is a landmark 2024 systematic review and network meta-analysis evaluating robotic-assisted radical prostatectomy (RARP) against traditional open and laparoscopic approaches. This comprehensive study, already garnering 7 citations, provides critical evidence that RARP offers superior perioperative outcomes, including reduced blood loss and shorter hospital stays, while maintaining comparable oncologic control. Liu’s research directly addresses the pressing clinical question of which surgical modality yields the best balance of efficacy and safety for localized prostate cancer. By synthesizing data from multiple trials, he has helped establish a clearer evidence hierarchy for urologists worldwide. His work exemplifies the rigorous comparative effectiveness research needed to guide treatment decisions in an era of rapidly advancing surgical technology. Liu’s meta-analysis has become a key reference for clinicians and researchers evaluating the role of robotic surgery in prostate cancer management, cementing his reputation as a thoughtful contributor to evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1